[Value of brain imaging in assessment of cognitive symptoms. Cognitive and emotional impact of antipsychotic drug treatment]].
Martinot
J L
JL
Unité de recherche méthodologique neuroimagerie en psychiatrie, INSERM-CEA ERM 02-05, Service Hospitalier Fréderic Joliot, 4, place du Général Leclerc, 91401 Orsay. jlmartinot@cea.fr
Peretti
C S
CS
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002540:Cerebral Cortex / Q000187:drug effects / Q000503:physiopathology; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D003952:Diagnostic Imaging; D065127:Dopamine D2 Receptor Antagonists; D004569:Electroencephalography; D004644:Emotions / Q000187:drug effects* / Q000502:physiology; D006212:Hallucinations / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008032:Limbic System / Q000187:drug effects / Q000503:physiopathology; D017448:Receptors, Dopamine D2 / Q000502:physiology; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012564:Schizophrenic Language; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D017448:Receptors, Dopamine D2